Author: Multibagger News

Anshul Maheshwari, the CFO of SI-BONE, Inc. (NASDAQ:SIBN), Sells Company Stock Worth $42,693 – Latest SEC Filings Revealed! Anshul Maheshwari, the Chief Financial Officer of SI-BONE, Inc. (NASDAQ:SIBN), has recently sold a total of $42,693 worth of company stock, according to the latest SEC filings. The transactions, which took place on July 2, 2024, involved the sale of company shares at prices ranging from $12.8973 to $12.9067. The sales were executed in multiple trades, with part of the shares being sold at a weighted average price of $12.8973 and the remainder at a weighted average of $12.9067. The exact number…

Breaking News: Cathie Wood’s ARK ETFs Make Bold Moves in Biotech Sector | Daily Trades Analysis July 5, 2024 In the fast-paced world of exchange-traded funds, Cathie Wood’s ARK ETFs are making waves with their focus on disruptive innovation. The latest daily trades on Friday, July 5, 2024, reveal significant moves in the biotech sector that could catch the eye of savvy investors. Leading the pack is ARK’s investment of $1,518,073 in Intellia Therapeutics Inc (NASDAQ:), acquiring a total of 66,147 shares. This bold move highlights ARK’s increasing stake in the gene-editing company, following a trend of consistent buying. On…

Carl Dambkowski, Chief Medical Officer of Apogee Therapeutics, Inc. (NASDAQ: APGE), Sells Over $225,000 Worth of Company Stock In a recent transaction, Carl Dambkowski, the Chief Medical Officer of Apogee Therapeutics, Inc., sold a significant amount of company stock totaling over $225,000. The sales were conducted at varying prices, with two separate transactions executed on July 3, 2024. The first sale involved 3,852 shares at an average price of $37.29 per share, while the second sale comprised 2,143 shares at an average price of $38.16 per share. These sales were carried out in accordance with a Rule 10b5-1 trading plan…

Michael Thomas Henderson Sells 15,000 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) Stock Michael Thomas Henderson, the CEO of Apogee Therapeutics, Inc. (NASDAQ: APGE), recently sold 15,000 shares of company stock for over $558,900. The transactions took place on July 5th, 2024, at an average price of $37.26 per share. Henderson’s direct holdings now amount to 1,474,487 shares of common stock. The sale was made under a Rule 10b5-1 trading plan, adopted by Henderson in 2023 to prevent insider trading claims. Investors monitoring Apogee Therapeutics may find this insider transaction noteworthy. Additionally, the company has made positive strides, including appointing Dr.…

Insider Transactions at Okta, Inc.: Director Sells 3,280 Shares In a recent Form 4 filing with the SEC, Okta, Inc. (NASDAQ:OKTA) director Jacques Frederic Kerrest sold 3,280 shares of Class A common stock for $313,689. The sale, which occurred on July 2, 2024, had an average price of $95.6369 per share, ranging between $95.175 and $96.03. Kerrest also acquired 3,280 shares of Class A common stock, converting Class B common stock, with no associated price. Insider transactions are closely monitored by investors for insights into the company’s valuation and future prospects. However, it’s essential to understand that insider sales can…

Discover the Inside Scoop on Biden’s Debate Performance Against Trump Read on to uncover U.S. President Joe Biden’s recent revelations about his debate with Donald Trump in an exclusive interview with ABC News. Find out the real reasons behind his shaky performance and what this could mean for his future. In the interview, Biden admitted to feeling unwell, exhausted, and poorly prepared for the debate, attributing his performance to a bad cold rather than a serious illness. He took full responsibility for his shortcomings and expressed regret for not trusting his instincts. Democrats are closely monitoring Biden’s ability to lead…

Blackstone Inc. Director Sells $14 Million Worth of Stock in Insider Transaction Blackstone Inc. (NYSE:BX) Director Joseph Baratta has recently sold 116,448 shares of company stock, totaling over $14 million, according to a recent SEC filing. The sale, conducted on July 3, 2024, at a weighted average price of $123 per share, raises questions about the company’s future prospects. Baratta’s sale was executed under a pre-established trading plan, Rule 10b5-1, which allows insiders to sell shares at predetermined times to avoid accusations of trading on nonpublic information. Despite the significant divestment, Baratta still holds 921,184 shares, maintaining a strong equity…

As the world’s best investment manager and financial market journalist, I am here to bring you the latest news on former President Donald Trump’s distancing from Project 2025, a conservative group’s ambitious plans for the next Republican presidency. Trump took to his Truth Social platform to renounce any connection with the project, stating that he knew nothing about it and disagreed with some of its assertions. The controversy surrounding Project 2025 stems from Heritage Foundation president Kevin Roberts’ comments about a second American Revolution, which many viewed as a veiled threat of violence. Despite the backlash, Roberts reiterated that Americans…

Corsair Gaming CFO Sells Stock: What Does It Mean for Investors?Discover the latest insider transaction at Corsair Gaming, Inc. (NASDAQ:CRSR) involving Chief Financial Officer Michael G. Potter. Get the scoop on the recent sale of 1,947 shares and what it means for the company’s future. Find out how this news ties into Corsair Gaming’s Q1 2024 earnings call and their plans for growth in the gaming market. As an investment manager, journalist, and SEO mastermind, I break down the implications of insider transactions for the average investor. Stay informed and make better financial decisions by understanding the latest news and…

Investing Insight: Biden Support Among Democrats Drops to 86% in Latest Poll – Wall Street Journal Analysis In a recent Wall Street Journal poll, 86% of Democrats indicated they would vote for U.S. President Joe Biden in a hypothetical match-up against former President Donald Trump. This figure is a decrease from the 93% of Democrats who expressed support for Biden back in February. The poll, conducted with 1,500 registered voters from June 29 to July 2, has a margin of error of plus or minus 2.5 percentage points for the entire sample. As the world’s best investment manager and financial…